Followers | 4047 |
Posts | 152923 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |

Wednesday, January 24, 2024 9:04:59 AM
Recent EVAX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/17/2025 12:30:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/11/2025 12:15:13 PM
- Evaxion finalizes agreement with EIB to convert debt into equity • GlobeNewswire Inc. • 07/11/2025 12:00:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/02/2025 10:00:25 AM
- Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio • GlobeNewswire Inc. • 07/01/2025 12:30:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/25/2025 12:15:08 PM
- Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus • GlobeNewswire Inc. • 06/25/2025 12:00:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2025 01:30:24 PM
- Evaxion receives grant funding to design new polio vaccine • GlobeNewswire Inc. • 06/03/2025 01:15:31 PM
- Evaxion announces business update and first quarter 2025 financial results • GlobeNewswire Inc. • 05/27/2025 11:30:48 AM
- Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025 • GlobeNewswire Inc. • 05/23/2025 12:00:51 PM
- Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01 • GlobeNewswire Inc. • 05/22/2025 12:00:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/05/2025 12:45:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2025 12:30:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2025 12:16:21 PM
- 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting • GlobeNewswire Inc. • 04/28/2025 12:00:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/10/2025 12:15:36 PM
- Evaxion to present at World Vaccine Congress • GlobeNewswire Inc. • 04/10/2025 12:00:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/07/2025 10:00:16 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/01/2025 01:33:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/01/2025 11:45:17 AM
- Evaxion announces business update and full year 2024 financial results • GlobeNewswire Inc. • 04/01/2025 11:30:35 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2025 12:15:31 PM
- Evaxion to announce business update and full year 2024 financial results on April 1, 2025 • GlobeNewswire Inc. • 03/27/2025 12:00:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/26/2025 08:30:23 PM
A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM
Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM